How Better Insights can Help Medical Affairs Teams Gain Strategic Ground
Ninety percent of the world’s data was generated in the past two years. In the next two years, the amount of information generated will continue…
Ninety percent of the world’s data was generated in the past two years. In the next two years, the amount of information generated will continue…
Too often ,when an issue emerges with data quality, business functions focus on how they can fix the issue to meet immediate production or compliance…
Ways to leverage technology in medical affairs to achieve more as the role evolves Perhaps more so than any other part of a life science…
Livia Ng, Founder and CEO of Neuroute explains the significance of diversity in clinical research and why it is a non-negotiable for science, for medicine…
European and US pharma companies have welcomed the EMA’s new clinical trials information system (CTIS), according to an Arriello survey. Arriello’s Kieran O’Donnell and Nicola…
It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical…
Most life sciences Regulatory teams still think and work in terms of documents, paragraphs and sentences when putting together collateral for marketing authorisation and variations…
The last 300 years have seen phenomenal evolution in our understanding of, and approach to managing human health and wellbeing. It’s fair to say that…
Released this July, the UK Government’s Women’s Health Strategy aimed to address a very complex problem – gender inequality across the healthcare sector. Whilst the…
Globally, researchers have long since been working on various aspects of medicine and clinical trials are a core part of developing medicinal and health development…